Research regarding HS, COVID-19, and related medications is ongoing as scientists continuously learn more about the disease.
The therapies given for HS maysuppressor moderate the immune system.
It is an autoinflammatory disease (which means your immune system is overactive) rather than anautoimmune disease.
PeopleImages / E+ / Getty Images
HS is not considered a specific risk factor for COVID-19.
HS is more prevalent among ethnic minorities.
This could lead to poorer outcomes.
Scientists are still learning about COVID-19 and its interaction with other conditions and medication.
Steroid medication or injections can also suppress the immune system.
There is currently no concern about people with HS on biological therapy having the COVID-19 vaccine.
Some early clinical trials suggest that being on an immunosuppressant medication impairs vaccine-induced immunity.
You should never stop any medication without the advice and guidance of your medical team.
Stopping your medication without advice can put you at risk of HS flares and worsening symptoms.
You may need to stop certain medications when having the COVID-19 vaccine.
My HS medical team offered me a video consultation rather than a face-to-face appointment.
Is it worth attending?
The COVID-19 pandemic has led to an increase in telecare rather than face-to-face appointments.
What can I do at home to help manage my HS?
attempt to maintain a healthy diet and lifestyle.
Also, ensure you look after your mental health as well as your physical health.
There are still questions about whether biologic medications and corticosteroids can reduce the effectiveness of the COVID-19 vaccines.
The information in this article is current as of the date listed.
As new research becomes available, we’ll update this article.
For the latest on COVID-19, visit ourcoronavirus news page.
Lima X, Cueva M, Alora M.COVID19 in patients with hidradenitis suppurativa.British Journal of Dermatology.
2021;12. doi:10.3389/fimmu.2021.656362
HS Foundation.COVID-19 vaccines: information for people with HS & their caregivers.
2020;83(2):e153-e154.
